Anti-Angiogenic Agents in Pancreatic Cancer: A Review

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-01 ,pp. : 464-469

Bentham Science Publishers

Access to resources Recommend Favorite

Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 10, 2010-12 ,pp. : 753-768

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite

Current status of cediranib: the rapid development of a novel anti-angiogenic therapy

By Lindsay Colin R   MacPherson Iain RJ   Cassidy Jim  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 421-432

Future Medicine

Access to resources Recommend Favorite

Anti-angiogenic therapy for osteosarcoma

By Quan Gerald  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 707-713

Springer Publishing Company

Access to resources Recommend Favorite